REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/13/2026
Back to search
Official data from USPTO
CUREVAC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
04/14/2026
Trademark type
Combined
Nice classes
1, 5, 42, 44
Filing date
09/03/2019
Registration date
04/13/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/13/2021
Last transaction
04/14/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
94
Owner location
TÜBINGEN, DE
Examiner
MARTIN, LIEF ANDREW
Law office
M30
Current location
TMO LAW OFFICE 112
Mark description
The mark consists of the stylized term "CUREVAC" with the term "CURE" appearing in orange, the term "VAC" appearing in blue, and with a blue curved line beginning at the letter "V", and extending to the right and below the wording.
Holders and representatives
Holders
C. S. (pessoa física)
CureVac AG
Representatives
Jennifer Fraser DYKEMA GOSSETT PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical reagents and biomoleculesin particular biological macromoleculesfor industrial or scientific purposes; Reagents for research purposes
Class 5
Chemical preparations for medical usefor therapeutic and prophylactic treatment of neurologicalneuromuscularneurodegenerativeinfectious and cardiovascular diseasesof autoimmune diseases and cancer diseasesof tumoursof allergiesof metabolic diseasesof heritable genetic diseasesfor therapies replacing proteins or enzymes; pharmaceutical preparationsimmunostimulantsin particular for human or veterinary medical purposes; pharmaceutical preparationsvaccinesin particular for human or veterinary medical purposes; pharmaceutical preparationsadjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromoleculesin particular for human or veterinary purposes for the treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor the treatment of infectious diseasesautoimmune diseases and tumoursfor treatment of cancersfor treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy productsnucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical usein particular substances for food supplementsdietary food supplements; Peptide carrier molecules for association with a biological macromoleculefor medical usefor use in facilitating delivery of a wide range of medicinal substances; Peptidic carrier molecule for preparing a pharmaceutical compositionfor medical use as a protein delivery preparation to expedite or improve delivery of a therapeutic macromolecule or prophylactic biological marcomolecule; Peptide carrier moleculesold in combination with a biological macromolecule for preparing a pharmaceutical compositionfor medical use as a protein delivery preparation to expedite or improve delivery of a therapeutic drug or prophylactic drug
Class 42
Scientific and technological services and researchin particular scientific research for identificationtesting and characterisation of biological macromolecules; medical testing servicespre-clinical and clinical testing of macromolecules; scientific research in the nature of discovery of biological macromolecules; Laboratory servicesrelated to custom manufacturing of pharmaceutical ingredientsfor identificationtesting and characterisation of biological macromolecules
Class 44
Medical and veterinary servicesin particular for therapeutic and prophylactic treatment of cancer diseasesinfectious diseasesautoimmune diseases or allergies; Medical and veterinary services for treating of hereditary disorders; Medical and veterinary services for protein or enzyme supplement therapy for therapeutic or prophylactic treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseases and for treatment of endocrinological or metabolic disorders
Publications
History of USPTO decisions and trademark events.
31 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/08/2023
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
09/30/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/30/2021
ES7R
TEAS SECTION 7 REQUEST RECEIVED
04/30/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
04/13/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/26/2021
PUBO
PUBLISHED FOR OPPOSITION
01/26/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/17/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
12/17/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/17/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
12/17/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/17/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/16/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/16/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/15/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/30/2020
GNRT
NON-FINAL ACTION E-MAILED
06/30/2020
CNRT
NON-FINAL ACTION WRITTEN
06/30/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/16/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/16/2020
ALIE
ASSIGNED TO LIE
06/15/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/04/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/09/2019
GNRT
NON-FINAL ACTION E-MAILED
12/09/2019
CNRT
NON-FINAL ACTION WRITTEN
12/09/2019
DOCK
ASSIGNED TO EXAMINER
12/05/2019
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/14/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/13/2019
NWAP
NEW APPLICATION ENTERED
09/06/2019
Continuous trademark protection
Get notified about every new filing that threatens CUREVAC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.